Some Women at Higher Risk of Serious Injuries from Yaz and Yasmin Birth Control
If this article sounds similar to a recent experience that you or a loved one have suffered from, please don’t hesitate to contact us online or call 859-578-4444 to schedule a free consultation!
Serious side effects and health problems caused by Yaz and Yasmin birth control have impacted women across the country.Yaz and Yasmin birth control pills have an ingredient called drospirenone, which is not found in other forms of birth control in the United States. Drospireonone is a synthetic progestin that can increase blood potassium levels.
Too much potassium in the blood can result in a condition known as hyperkalemia, leading to blood clots, heart attacks or stroke.Women who already have high levels of potassium in their blood are especially at risk of suffering serious health problems from Yaz or Yasmin. Also, women who are taking medications that could increase potassium levels, such as Heparin, Motrin, Aleve or Advil, could be in danger.
Yaz is manufactured by Bayer USA and is one of the top selling birth control pills on the market. This drug was approved by the U.S. Food and Drug Administration (FDA) in March 2006 and has been under scrutiny for its TV commercials that downplayed the potential adverse health effects. In October 2008, the FDA found two Yaz commercials to be deceptive and sent a warning letter to the manufacturer.
Many women have reported that Yaz and Yasmin caused them to suffer serious health problems. As a result, numerous lawsuits have been filed against Bayer. Some of the reported medical conditions include:
- Heart attack
- Stroke
- Pulmonary embolism
- Kidney disease
- Deep vein thrombosis
- Death
If you have suffered a serious illness or medical condition from taking the birth control, Yaz or Yasmin, you may be able to pursue compensation for your injuries. Contact an experienced Louisville dangerous drugs injury lawyer at the Law Office of Hendy Johnson Vaughn Emery at (859) 578-4444 or (888) 606-5297 for more information.